Arrowhead Pharmaceuticals, Inc. (ARWR)
BMV
Closed
Oct 5, 2026
Day's Range
454.5552 wk Range
454.55Overview - ARWR - Arrowhead Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
1.16T
P/E (Trailing)
‪-45,454.99‬
PEG Ratio
‪-5,727.32‬
Price / Sales (TTM)
‪95.63‬
Price / Book
‪7.76‬
EV / EBITDA
‪-318.93‬
Profitability
Profit Margin
‪-47.79%‬
Operating Margin
‪-226.02%‬
Return on Assets
‪-8.10%‬
Return on Equity
‪-55.20%‬
Ownership
Shares Outstanding
141.13M
Float
122.44M
Held by Insiders
‪3.65%‬
Held by Institutions
‪85.43%‬
Price stats
Beta
‪1.28‬
50-Day Avg
‪454.55‬
200-Day Avg
‪454.55‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - ARWR - Arrowhead Pharmaceuticals, Inc.
Peers - ARWR - Arrowhead Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- ARWRBMVArrowhead Pharmaceuticals, Inc.64.02BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt1.05TMarket Cap+10.77%52-week change36.36P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals, Inc.742.50BMarket Cap-51.02%52-week change53.47P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE American Depositary Share413.38BMarket Cap-18.50%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- ASND1NBMVAscendis Pharma A/S291.08BMarket Cap+3.50%52-week change19.80P/E (Trailing)‪70.84%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.213.89BMarket Cap+10.22%52-week change172.39P/E (Trailing)‪2.14%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals, Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - ARWR - Arrowhead Pharmaceuticals, Inc.
About
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines for intractable diseases using RNA interference, a gene-silencing approach designed to reduce the production of disease-causing proteins. Arrowhead Pharmaceuticals focuses on therapeutic areas including cardiometabolic, liver,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
